NDR1 mediates PD-L1 deubiquitination to promote prostate cancer immune escape via USP10
Abstract Prostate cancer (PCa) is one of the most common male genitourinary system malignancies. Despite the significant benefits of anti-PD-L1 immune checkpoint inhibitor therapy in other cancers, the reasons for its poor therapeutic efficacy in prostate cancer (PCa) remain unclear.NDR1 plays an im...
| المؤلفون الرئيسيون: | , , , , , , , , , , , |
|---|---|
| التنسيق: | مقال |
| اللغة: | English |
| منشور في: |
BMC
2024-09-01
|
| سلاسل: | Cell Communication and Signaling |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://doi.org/10.1186/s12964-024-01805-5 |